We are live on ! Find out more
ID

Integral Derivatives Portfolio holdings

AUM $4.07B
1-Year Est. Return 19.81%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+19.81%
3 Year Est. Return
+45.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$88.5M
Cap. Flow
-$112M
Cap. Flow %
-2.03%
Top 10 Hldgs %
52.24%
Holding
1,517
New
409
Increased
321
Reduced
370
Closed
398
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
5.6 quarters
Top 20 Avg Time Held Equity + Options
5.7 quarters
Avg Time Held Equity only
1.2 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.28%
2 Technology 1.29%
3 Communication Services 0.77%
4 Energy 0.75%
5 Healthcare 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ARAY icon
1151
Accuray
ARAY
$22.7M
– –
-12,104
Closed -$56K –
ASHR icon
1152
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.37B
– –
-19,321
Closed -$453K –
ASHR icon
1153
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.37B
– –
-24,800
Closed -$582K –
AVGO icon
1154
Broadcom
AVGO
$1.71T
– –
-71,500
Closed -$1.47M –
AXON icon
1155
CALL
Axon Enterprise
AXON
$33.6B
– –
-15,200
Closed -$368K –
AXP icon
1156
American Express
AXP
$209B
– –
-27,266
Closed -$2.13M –
AZN icon
1157
AstraZeneca
AZN
$242B
– –
-4,548
Closed -$265K –
AZN icon
1158
PUT
AstraZeneca
AZN
$242B
– –
-3,950
Closed -$216K –
BAX icon
1159
PUT
Baxter International
BAX
$12.9B
– –
-40,300
Closed -$1.79M –
BBD icon
1160
PUT
Banco Bradesco
BBD
$44.4B
– –
-117,889
Closed -$531K –
BBY icon
1161
Best Buy
BBY
$18.4B
– –
-13,923
Closed -$622K –
BCRX icon
1162
CALL
BioCryst Pharmaceuticals
BCRX
$2.06B
– –
-11,500
Closed -$73K –
BCS icon
1163
CALL
Barclays
BCS
$76.9B
– –
-126,713
Closed -$1.31M –
BCS icon
1164
PUT
Barclays
BCS
$76.9B
– –
-20,889
Closed -$217K –
BKNG icon
1165
Booking.com
BKNG
$118B
– –
-201,200
Closed -$13.3M –
BMRN icon
1166
CALL
BioMarin Pharmaceuticals
BMRN
$10.5B
– –
-3,400
Closed -$282K –
BNS icon
1167
Scotiabank
BNS
$110B
– –
-5,900
Closed -$329K –
BOX icon
1168
Box
BOX
$5.15B
– –
-21,102
Closed -$292K –
BRK.B icon
1169
Berkshire Hathaway Class B
BRK.B
$1.11T
– –
-14,998
Closed -$2.51M –
BRK.B icon
1170
PUT
Berkshire Hathaway Class B
BRK.B
$1.11T
– –
-11,500
Closed -$1.87M –
BX icon
1171
Blackstone
BX
$82.6B
– –
-41,140
Closed -$1.24M –
CAH icon
1172
CALL
Cardinal Health
CAH
$55.5B
– –
-5,300
Closed -$381K –
CC icon
1173
PUT
Chemours
CC
$1.99B
– –
-15,720
Closed -$348K –
CCEP icon
1174
Coca-Cola Europacific Partners
CCEP
$46.3B
– –
-22,200
Closed -$697K –
CCEP icon
1175
PUT
Coca-Cola Europacific Partners
CCEP
$46.3B
– –
-20,200
Closed -$634K –

Similar funds

Integral Derivatives's Q1 2017 Portfolio in Review

As of Q1 2017, Integral Derivatives held 1,517 positions worth $5.49B, up 1.6% from $5.4B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Integral Derivatives's Q1 2017 filing shows 409 new, 321 increased, 370 reduced and 398 closed positions. Its largest new stake was IBM: 117,858 shares worth $19.6M. The largest sale was Meta Platforms (Facebook), an estimated $60M.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 93% a quarter earlier, followed by Technology and Communication Services.

  • Integral Derivatives's largest Q1 2017 buy was IBM: 117,858 shares worth $19.6M.
  • Integral Derivatives added most to Alphabet (Google) Class A in Q1 2017, an estimated $5.07M increase.
  • Integral Derivatives's biggest Q1 2017 reduction was Meta Platforms (Facebook), cutting an estimated $60M.
  • Integral Derivatives fully exited Booking.com in Q1 2017, selling an estimated $13.3M.
  • Integral Derivatives's ten largest holdings make up 52% of its $5.49B portfolio in Q1 2017.
  • Integral Derivatives opened 409 new positions and closed 398 in Q1 2017.
  • Integral Derivatives's portfolio value rose 1.6% quarter-over-quarter to $5.49B.

Based on Integral Derivatives's 13F filing for Q1 2017, filed 15 May 2017.